Quantcast

Latest stem cell therapy Stories

2014-05-02 23:04:19

The global stem cell therapy market on the basis of the mode of treatment is segmented into allogeneic and autologous stem cell therapy. http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html (PRWEB) May 02, 2014 The report “Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis &...

2014-04-29 09:52:38

New research looking at the success of clinical trials of stem cell therapy shows that trials appear to be more successful in studies where there are more discrepancies in the trial data. Researchers from Imperial College London conducted a meta-analysis of 49 randomised controlled trials of bone marrow stem cell therapy for heart disease. The study, published today in the British Medical Journal, identified and listed over 600 discrepancies within the trial reports. Discrepancies were...

2014-04-23 16:29:59

DALLAS, April 23, 2014 /PRNewswire/ -- According to the new research report "Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020" published by MarketsandMarkets, The Stem Cell Therapy Market is poised to grow at a CAGR of 39.5% from 2015 to 2020, to reach $330 Million by 2020....

2014-04-01 08:30:20

Safety, Efficacy, Patient Satisfaction Drive StemGenex' Efforts toward Best-in-Class Stem Cell Treatment LA JOLLA, Calif., April 1, 2014 /PRNewswire/ -- StemGenex®, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases today reinforced their commitment to attaining the highest treatment standards in the U.S. StemGenex believes by focusing on three key areas of treatment, patients will continue...

2014-03-18 23:21:46

$8.9M Raised in Last Round Enables Heart Institute to Treat Patients with Ischemic Conditions with Their Own Adult Stem Cells Beginning Summer, 2014 in the Bahamas Freeport, Bahamas (PRWEB) March 18, 2014 Okyanos Heart Institute, whose mission it is to bring a new standard of care and a better quality of life to patients with coronary artery disease (CAD) using adult stem cell therapy, announced today it has raised $8.9 million in its Series B offering. Passion Group founder Ali Shawkat...

2014-03-18 12:33:00

New position focuses on StemGenex' commitment to safety and efficacy while developing new technology. LA JOLLA, Calif., March 18, 2014 /PRNewswire/ -- StemGenex®, a leader in adult adipose-derived stem cell therapy, is pleased to announce that Jeremiah McDole, Ph.D. has been named Director of Clinical Research and Development. http://photos.prnewswire.com/prnvar/20140318/LA85529 "We couldn't be more excited to welcome Jeremiah," said Rita Alexander, President of StemGenex....

2014-03-10 23:24:01

Adult Stem Cell Therapy Trade Organization Expands Advisory Board After Successful Global Conference with Researchers, Scientists, Regulatory Experts, Physicians And Investors Freeport, The Bahamas (PRWEB) March 10, 2014 Matt Feshbach, CEO of Okyanos Heart Institute whose mission it is to bring a new standard of care and better quality of life to patients with coronary artery disease using cardiac stem cell therapy has announced the appointment of Okyanos’ senior vice president of...

2014-02-20 23:00:05

The panel of presenters will discuss opportunities for medical industry start-ups in the Bahamas after recent stem cell research and Therapy Act Freeport, The Bahamas (PRWEB) February 21, 2014 Okyanos Heart Institute, whose mission it is to bring a new standard of care and a better quality of life to patients with coronary artery disease using adult stem cell therapy, announces CEO Matt Feshbach will present at the STEMSO Conference. He will join a panel to discuss the opportunities...

2014-02-11 08:33:38

StemGenex is now providing access to its latest stem cell therapy for patients diagnosed with COPD through nebulized stem cells. These treatments are being studied with expertise by board certified MD's in the United States. LA JOLLA, Calif., Feb. 11, 2014 /PRNewswire/ -- StemGenex®, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases, today announced the newest therapy to assist patients...

2014-02-03 12:27:00

LONDON, Feb. 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Stem Cell Markets A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. Recent understanding of stem cell biology...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related